WHO Reports Gaps in Testing and Treatment for Antimicrobial Resistance
|
The facts
- About one in six laboratory-confirmed bacterial infections worldwide in 2023 was resistant to antibiotics.
- WHO says gaps in testing and treatment leave many patients at risk from antimicrobial resistance.
- More than 90% of countries report having national action plans to address antimicrobial resistance.
- Antimicrobial resistance can make common infections harder to treat.
- Drug-resistant infections can increase risks during surgery, childbirth and cancer care.
- WHO says countries need stronger prevention, diagnosis and appropriate antibiotic use.
- WHO estimates that more than one million people died directly from antimicrobial resistance in 2021.
Context
What is antimicrobial resistance?
It occurs when bacteria and other microbes become resistant to medicines intended to treat them, reducing the effectiveness of available treatments. who.int tagesschau.de
Why does testing matter?
WHO says gaps in testing and treatment mean many patients remain at risk; diagnosis is also among the areas where it says countries need stronger action. who.int stern.de
How many countries have antimicrobial-resistance plans?
WHO says 173 countries report developing plans to address antimicrobial resistance, compared with 79 countries previously. who.int
Where Left and Right agree
Left and right largely agree on this one.
- What both sides accept
- Plans on paper aren't enough — countries must fund and deliver actual testing, prevention and appropriate antibiotic use to stop drug resistance.
- Where Left and Right differ in emphasis
- Both demand real implementation over paperwork: one stresses building diagnostic and treatment infrastructure, the other stresses disciplined prescribing to protect future patients.
- Watch for
- Watch whether the number of countries reporting both funded and implemented AMR plans moves beyond the 42 of 183 surveyed that WHO counted this round.AOL.com
How left and right read it
A plan on paper is not a public health system; diagnostic capacity is. More than 90% of countries report national action plans, yet gaps in testing and treatment still leave patients at risk, with one in six confirmed bacterial infections already resistant in 2023 and over a million deaths directly attributed in 2021. Fund the labs, the prevention, the appropriate prescribing.
Antibiotics are a finite inheritance; careless prescribing spends them on the patients who come next — those facing surgery, childbirth or cancer care, where resistant infections raise the risk. One in six confirmed infections was resistant in 2023, with more than a million deaths attributed directly in 2021. Plans are cheap. More than 90% of countries have one, so what is each doing to deliver prevention, diagnosis and disciplined prescribing?
The receipts — 73 sources
Other coverage (73)
A news briefing built to show both sides.
The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.